Together, these data demonstrate that HER3–tyrosine phosphorylation is primarily regulated by Met in a MET-amplified setting, and the consistent observation of this across seven independently derived cell lines further indicates that tyrosine phosphorylation of HER3 by Met is under strong selection in MET-amplified cancers. This evidence concerns the gene ERBB3 and cancer.